We are live on
!
Find out more
SS
Spinecap SAS Portfolio holdings
AUM
$335M
1-Year Est. Return
16.94%
This Fund
S&P 500
This Quarter
Est. Return
+13.49%
1 Year Est. Return
+16.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$192M
AUM Growth
–
Cap. Flow
+$175M
Cap. Flow
% of AUM
90.86%
Top 10 Holdings %
Top 10 Hldgs %
89.94%
Holding
12
New
12
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$30.7M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$27.3M |
| 3 |
Lam Research
LRCX
|
+$26.4M |
| 4 |
KLA
KLAC
|
+$14.1M |
| 5 |
United Rentals
URI
|
+$14.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.64% |
| 2 | Financials | 25.29% |
| 3 | Healthcare | 15.5% |
| 4 | Communication Services | 15.29% |
| 5 | Industrials | 8.25% |
Similar funds
RWI
PCM
HGA
MAM
PHWM
PMA
HFS
VFIC
Spinecap SAS's Q2 2025 Portfolio in Review
Q2 2025 is the first quarter with a 13F filing on record for Spinecap SAS, which disclosed 12 positions worth $192M. Its ten largest holdings account for 90% of the portfolio.
Its largest position is Thermo Fisher Scientific: 73,444 shares worth $29.8M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, followed by Financials and Healthcare.
- Spinecap SAS's largest Q2 2025 buy was Thermo Fisher Scientific: 73,444 shares worth $29.8M.
- Spinecap SAS's ten largest holdings make up 90% of its $192M portfolio in Q2 2025.
- Spinecap SAS disclosed 12 positions in Q2 2025, its first 13F filing on record.
Based on Spinecap SAS's 13F filing for Q2 2025, filed 16 Jan 2026.